- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04969692
Local Warming Technique for Arterial Cannulation in Adult Patients
August 9, 2024 updated by: Kim Hee Young, Pusan National University Yangsan Hospital
Local Warming Technique for Arterial Cannulation in Adult Patients Under Heart Surgery-A Randomized Controlled Trial
Based on the fact that arterial vasodilation can be advantageous for endovascular catheterization and that an increase in body temperature can cause vasodilation by activating the cholinergic active vasodilator system, this study was planned to observe whether there was a significant change in the diameter of artery through ultrasound and to confirm the effectiveness of heating in the traditional palpation technique and the US-guided technique after local warming of the insertion site of arterial catheter in adult patients undergoing cardiac surgery.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Arterial cannulation is one of the important clinical techniques commonly used for real-time monitoring of blood pressure changes or when repeated blood tests are required.
However, complications such as bleeding, hematoma, and vascular occlusion may occur if the operator has little or no experience in the procedure, or if arterial cannulation is not easy due to the patient's underlying disease and systemic factors.
This situation prolongs the anesthesia induction time and may cause great harm to the patient in cases with a high bleeding tendency, such as in cardiac surgery.
Various studies have reported various arterial cannulation techniques so far, and there have been many advances in arterial cannulation techniques due to the general use of ultrasound (hereafter US).
However, there is still a risk of complications due to inexperience in the use of US or poor vascular status of the patient.
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Yangsan, Korea, Republic of
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult patients over 18 years of age undergoing cardiac surgery under general anesthesia
Exclusion Criteria:
- If the patient already has an arterial catheter and does not need additional arterial cannulation.
- When arterial cannulation is performed on an artery other than the radial artery due to the surgical technique or the patient's condition.
- When the patient's condition is urgent, such as emergency surgery, and there is no time to proceed with the research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: non-warming group
non-warming of local skin (puncture site)
|
|
|
Active Comparator: warming group
warming to increase local skin (puncture site) temperature
|
According to the group of participants, investigator applies the warmer to the hands and wrists of the participants, makes a local temperature of 40℃ gradually, and maintains it for about 10 minutes in warming group (which is divided in to warming-palpation (WP) and warming-US (WU) group).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes of the diameter of the artery
Time Frame: from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Investigator measures where there is a significant increase in the diameter of the artery due to warming using US.
|
from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
|
changes of the cross-sectional area of the artery
Time Frame: from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Investigator measures where there is a significant increase in the cross-sectional area of the artery due to warming using US.
|
from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
|
Success rate of first trial for arterial cannulation
Time Frame: from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Investigator measures success rate of first trial for arterial cannulation.
|
from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications related with arterial cannulation
Time Frame: from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Investigator measures where there are complications such as hematoma, vasopasm, and ischemia.
|
from time point of warming to success of arterial cannulation (the day of surgery, up to 1hour)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hee Young Kim, MD, PhD, Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 5, 2021
Primary Completion (Actual)
March 29, 2022
Study Completion (Actual)
March 29, 2022
Study Registration Dates
First Submitted
July 8, 2021
First Submitted That Met QC Criteria
July 16, 2021
First Posted (Actual)
July 21, 2021
Study Record Updates
Last Update Posted (Actual)
August 12, 2024
Last Update Submitted That Met QC Criteria
August 9, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05-2021-117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Disease Which Should be Treated by Surgery
-
Baskent UniversityActive, not recruitingoPAP Should be > 25mmHg in Right Heart Catheterization at Rest | There Should be Patients Who Will Undergo Non-cardiac and Non-obstetric SurgeryTurkey
-
University of TurkuBrigham and Women's HospitalActive, not recruitingCoronary Artery Disease | Atrial Fibrillation | Aortic Valve Stenosis | Aortic Valve Disease | Cardiac Surgery | Cardiac Arrythmias | Mitral Valve Disease | Cardiac TumorFinland
-
Heart Center BH TuzlaUnknownPatients With Coronary Artery Disease Scheduled for by Pass SurgeryBosnia and Herzegovina
-
The First Affiliated Hospital of Zhengzhou UniversityHenan Provincial People's Hospital; Second Affiliated Hospital of Zhengzhou...RecruitingLocally Advanced Cervical Cancer | Female, Age ≥ 18 Years Old | No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy | ECOG Score of 0-1 | Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed... and other conditionsChina
-
Hasselt UniversityJessa Hospital; Ziekenhuis Oost-Limburg; Algemeen Ziekenhuis Vesalius; Ziekenhuis... and other collaboratorsCompletedSepsis, Cancer, Heart Attack, Heart Failure, Abdominal Surgery, Trauma, Diabetes, Lung Disease, Gynaecology, Fertility, Cardiac Surgery,Belgium